Chemed Corp
(FRA:CXM)
€
496
0 (0%)
Market Cap: 7.48 Bil
Enterprise Value: 7.32 Bil
PE Ratio: 28.66
PB Ratio: 6.79
GF Score: 94/100 - Q1 2024 Chemed Corp Earnings Call TranscriptApr 25, 2024€565 (-0.88%)Earnings
- Q4 2023 Chemed Corp Earnings Call TranscriptFeb 28, 2024€545 (-1.80%)Earnings
- Chemed Corp at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Chemed Corp at Bank of America Home Care Conference (Virtual) TranscriptDec 04, 2023
- Q3 2023 Chemed Corp Earnings Call TranscriptOct 26, 2023€472 (+0.43%)Earnings
- Q2 2023 Chemed Corp Earnings Call TranscriptJul 27, 2023€482 (-4.55%)Earnings
- Chemed Corp at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Chemed Corp at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Chemed Corp at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Chemed Corp Earnings Call TranscriptApr 27, 2023€500 (-1.96%)Earnings
- Chemed Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Q4 2022 Chemed Corp Earnings Call TranscriptFeb 24, 2023€476 (-1.24%)Earnings
- Chemed Corp at Bank of America Securities Home Care Conference (Virtual) TranscriptDec 05, 2022
- Chemed Corp at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Chemed Corp Earnings Call TranscriptNov 01, 2022€464 (+2.65%)Earnings
- Q2 2022 Chemed Corp Earnings Call TranscriptJul 28, 2022€476 (-5.74%)Earnings
- Chemed Corp at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Chemed Corp at RBC Capital Markets Global Healthcare Conference TranscriptMay 18, 2022
- Chemed Corp at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Chemed Corp Earnings Call TranscriptApr 27, 2022€448 (-1.75%)Earnings
- Chemed Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 16, 2022
- Q4 2021 Chemed Corp Earnings Call TranscriptFeb 25, 2022€402 (+2.03%)Earnings
- Chemed Corp at Bank of America Securities Home Care Conference (Virtual) TranscriptDec 07, 2021
- Q3 2021 Chemed Corp Earnings Call TranscriptOct 29, 2021€392 (+4.81%)Earnings
- Q2 2021 Chemed Corp Earnings Call TranscriptJul 28, 2021€406 (+2.01%)Earnings
- Chemed Corp at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Chemed Corp at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Chemed Corp Earnings Call TranscriptApr 28, 2021€374 (-1.58%)Earnings
- Chemed Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 17, 2021
- Q4 2020 Chemed Corp Earnings Call TranscriptFeb 24, 2021€390 (+1.04%)Earnings
- Chemed Corp at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 10, 2020
- Q3 2020 Chemed Corp Earnings Call TranscriptOct 30, 2020€406 (+2.01%)Earnings
- Q2 2020 Chemed Corp Earnings Call TranscriptJul 30, 2020€390 (+2.63%)Earnings
- Chemed Corp at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2020
- Chemed Corp Annual Shareholders Meeting TranscriptMay 18, 2020
- Chemed Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Chemed Corp Earnings Call TranscriptApr 29, 2020€400 (-3.38%)Earnings
- Q4 2019 Chemed Corp Earnings Call TranscriptFeb 19, 2020€460 (+1.77%)Earnings
- Chemed Corp at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 13, 2019
- Q3 2019 Chemed Corp Earnings Call TranscriptOct 30, 2019€370 (+0.54%)Earnings
- Q2 2019 Chemed Corp Earnings Call TranscriptJul 26, 2019€346.75 (+3.76%)Earnings
- Chemed Corp at Jefferies Healthcare Conference TranscriptJun 05, 2019
- Chemed Corp at RBC Capital Markets Healthcare Conference TranscriptMay 21, 2019
- Chemed Corp at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Chemed Corp Earnings Call TranscriptApr 30, 2019€280.6 (-5.06%)Earnings
- Chemed Corp at Oppenheimer Healthcare Conference TranscriptMar 19, 2019
- Q4 2018 Chemed Corp Earnings Call TranscriptFeb 21, 2019€279.28 (+0.67%)Earnings
Chemed Corp at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 19, 2021 / 02:20PM GMT
Release Date Price:
€390
(-1.52%)
Frank George Morgan
RBC Capital Markets, Research Division - MD of Healthcare Services Equity Research & Analyst
(technical difficulty) services and managed care coverage universe. Today, we have Chemed Corporation in our next fireside chat.
With us today, we have Chemed CFO, Dave Williams, along with the CEO of VITAS and the EVP of Chemed, Nick Westfall. So welcome, gentlemen.
David P. Williams
Chemed Corporation - Executive VP & CFO
Thanks, Frank.
Nicholas Michael Westfall
VITAS Healthcare Corporation - CEO & President
Thanks, Frank. Great to be here.
Questions & Answers
Frank George Morgan
RBC Capital Markets, Research Division - MD of Healthcare Services Equity Research & Analyst
Look, why don't we first start out, maybe at a high level here, kind of assessing and looking at and evaluating the regulatory and maybe the more -- maybe the policy backdrop for hospice today. We'll talk more about the payment updates and those kind
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)